Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Final results from the prospective phase III WSG-ARA trial: impact of adjuvant darbepoetin alfa on event-free survival in early breast cancer.

Authors
Type
Published Article
Journal
Annals of Oncology
1569-8041
Publisher
Oxford University Press
Publication Date
Volume
25
Issue
1
Pages
75–80
Identifiers
DOI: 10.1093/annonc/mdt505
PMID: 24356620
Source
Medline
Keywords
  • Adjuvant Chemotherapy
  • Anemia
  • Breast Cancer
  • Epoetin
  • Safety

Abstract

Statistics

Seen <100 times